Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair restoration. RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia. RCS-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells, a type of fibroblast cell isolated from the hair follicle to repair and regenerate tissue. RCT-01 provides a source of collagen expressing cells to the site of injury, addressing the underlying cause of tendinosis. It has also developed an injection device, DermaPrecise, which improves the administration of its cell therapy products and certain other injectables.


TSXV:RP - Post by User

Post by Ingiboyon Dec 23, 2022 2:57pm
166 Views
Post# 35190193

Shares for Debt

Shares for DebtHere we go again.  
Question: Do we need some of these Directors when the company is running on fumes ?


REPLICEL ANNOUNCES DEBT SETTLEMENT

RepliCel Life Sciences Inc. intends to settle debt in the amount of $287,378.32 owed by the company to certain creditors by the issuance of 3,193,092 common shares of the company at a price of nine cents per share. 

The proposed debt settlement is subject to the approval of the TSX Venture Exchange and entry into debt settlement agreements with the creditors. All securities issued in connection with the debt settlement will be subject to a statutory hold period expiring four months and one day after issuance of the securities. 

Each of David Hall, Peter Lowry, Peter Lewis, Andrew Schutte, Gary Boddington and Kevin McElwee will be participating in the debt settlement and each are considered to be a related party within the meaning of Multilateral Instrument 61-101 Protection of Minority Security Holders in Special Transactions and each issuance is considered to be a related party transaction within the meaning of MI 61-101 but each issuance will be exempt from the valuation requirement of MI 61-101 by virtue of the exemption contained in Section 5.5(b) as the company's shares are not listed on a specified market and from the minority shareholder approval requirements of MI 61-101 by virtue of the exemption contained in Section 5.7(a) of MI 61-101 in that the fair market value of the consideration of the shares to be issued to each related party does not exceed 25 per cent of the company's market capitalization.

Then we get this to close the day:

Recent Trades - Last 10 of 11
Time ET Ex Price Change Volume Buyer Seller Markers
14:22:42 V 0.07 -0.02 2,000 7 TD Sec 7 TD Sec K
14:22:42 V 0.07 -0.02 6,000 7 TD Sec 1 Anonymous K
14:20:04 U 0.07 -0.02 3,000 1 Anonymous 79 CIBC K
14:20:04 U 0.07 -0.02 10,000 1 Anonymous 79 CIBC K
14:20:04 H 0.07 -0.02 5,000 33 Canaccord 79 CIBC K
14:20:04 H 0.07 -0.02 5,000 33 Canaccord 79 CIBC K
14:11:54 V 0.075 -0.015 4,000 79 CIBC 79 CIBC K
14:11:54 V 0.075 -0.015 6,000 79 CIBC 79 CIBC K
14:11:54 V 0.075 -0.015 10,000 1 Anonymous 79 CIBC KL
14:11:54 M 0.08 -0.01 9,000 1 Anonymous 79 CIBC
 

Yes you saw that right, we closed the day at $.07 CDN.  ($.05 US). We have reached the all time low share price for this stock.  


<< Previous
Bullboard Posts
Next >>